The goal of this Phase l project is to isolate a temperature sensitive mutant of streptavidin that will bind biotin at 4C but not at 4OC. This will be accomplished by chemical mutagenesis to saturate the streptavidin gene with mutations. A scheme for enriching for the temperature sensitive mutant will be employed. The library of mutants and the enriched library will both be screened using a computer assisted system for colony screening to find candidate mutants. These mutants will be characterized and the resulting mutants are expected to provide a valuable and novel addition to avidin-biotin technology.

Proposed Commercial Applications

This project will result in the isolation of a novel form of streptavidin that will allow for the conditional binding of biotynlated substrates. This will be particularly useful in affinity purification applications, isolation of specific antibody producing cells for production of monoclonal antibodies, and isolation of specific subsets of cells from mixed populations, such as blood progenitor cells to he used in autografts after chemotherapy in cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA068821-01
Application #
2112855
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (02))
Project Start
1995-09-15
Project End
1996-02-14
Budget Start
1995-09-15
Budget End
1996-02-14
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Western Research Company, Inc.
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85741
Countouriotis, Athena; Moore, Theodore B; Sakamoto, Kathleen M (2002) Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells 20:215-29
Mendoza, M J; Wang, C X; Lin, M et al. (2002) Fizzy-related RNA expression patterns in mammalian development and cell lines. Mol Genet Metab 76:363-6